Erev Tubb, MD, FACP

Erev Tubb, MD, FACP

Oncology in Mullica Hill, NJ

Hide Show

Speaks English and French


 (856) 508-3575

Contact


Hide Show

Office Hours

Monday:
9:00 am - 5:00 pm
Tuesday:
9:00 am - 5:00 pm
Wednesday:
9:00 am - 5:00 pm
Thursday:
9:00 am - 5:00 pm
Friday:
9:00 am - 5:00 pm
Saturday:
Closed
Sunday:
Closed
Hide Show

About Dr. Tubb


Dr. Erev Tubb, MD, FACP is a medical oncologist and hematologist in Mullica Hill, New Jersey.

He is available to see patients, with same day appointments available at 700 Mullica hill road, Suite 300, Mullica Hill, NJ 08062. Tel: 856-508-3575

He is currently licensed to practice medicine in New Jersey, Delaware, and Pennsylvania.

He is currently the medical director of the Mullica Hill Cancer Center at Inspira Health.

He was previously the Chair of Medicine, Chief of Hematology and Medical Oncology, Medical Director of the infusion center, and Vice-President of the Medical staff at St. Francis Hospital in Wilmington, DE.

He is affiliated with the Mullica Hill Cancer Center a part of Inspira Health Network, an American College of Surgeons accredited cancer center.

Delaware Today Top Doc 2019, 2018, 2017, 2016 and 2013.
Main Line Magazine Top Doc 2014, 2013, 2011, 2010.

Dr. Tubb has presented data at national meetings, he has several publications in peer reviewed journals, and is the author of a chapter on the pharmacology of anticoagulants.

Dr. Tubb contributes to the education of Family Medicine residents through clinical rounds, lectures, grand rounds and regular Tumor Boards.

Hide Show

Services Offered



Amyloidosis
Hematologic oncology
Breast cancer
Lung cancer
Skin cancer
Thrombocytopenia
Myelodysplasia
Myelofibrosis
Multiple myeloma
Lymphoma
Medical oncology
General / Benign hematology
Leukemia
Leukopenia

Qualifications and Experience



Hide Show

Education & Training

Thomas Jefferson University
Fellowship, Hematology/Oncology, 2005 - 2008

Thomas Jefferson University
Residency, Internal Medicine, 2002 - 2005

Sidney Kimmel Medical College
Class of 2002

Johns Hopkins University
BA, Biology & French Literature, 1993 - 1997

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Certifications

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology

National Board of Physicians and Surgeons
Hematology

National Board of Physicians and Surgeons
Medical Oncology

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

DE State Medical License
2009 - 2021

NJ State Medical License
2008 - 2021

PA State Medical License
2005 - 2020

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Work Experience

Medical Director
Inspira Health Network
Mullica Hill, NJ
Mullica Hill Cancer Center
2019 - Present

Medical Director
Hematology Oncology At St Francis Healthcare
Wilmington, DE
2015 - 2019

Clinical Assistant Professor, Medicine
Temple University
Philadelphia, PA
2014 - 2017

Department Chairman
St. Francis Hospital
Wilmington, DE
2011 - 2019

Oncologist
Associates in Hematology-Oncology
Upland, PA
2008 - 2015

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Hospital Affiliations

St. Francis Hospital
Current Affiliation
Wilmington, DE

Thomas Jefferson University Hospitals
Current Affiliation
Philadelphia, PA

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

TopDoc
Delaware Today, 2013, 2016-2019

TopDoc
MainLine Today, 2010-2011, 2013-2014

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

American Society of Hematology - ASH
Member

American College of Physicians - ACP
Member

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
Nat Med
Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F. M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., Levitsky, H. I.
1999 Jul
353 citations

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.
Proc Natl Acad Sci U S A
Sotomayor, E. M., Borrello, I., Tubb, E., Allison, J. P., Levitsky, H. I.
1999 Sep 28
127 citations

Journal Article

A proposed steroid mobilization test to separate margination from marrow suppression and to determine drug cessation for safety in lenalidomide-induced neutropenia in non-del(5q) MDS low and int-1 patients
Blood
Philip A. Pancari, Emmanuel C. Besa, Jackie Quan, Amanda Padula, Erev E. Tubb, and Raymond Vivacqua
11/16/2012

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄